108 research outputs found
High risk groups in cutaneous oncology : basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis
High risk groups in cutaneous oncology:basal cell nevus syndrome, xeroderma pigmentosum and epidermodysplasia verruciformis
Exosome mimetics: a novel class of drug delivery systems
The identification of extracellular phospholipid vesicles as conveyors of cellular information has created excitement in the field of drug delivery. Biological therapeutics, including short interfering RNA and recombinant proteins, are prone to degradation, have limited ability to cross biological membranes, and may elicit immune responses. Therefore, delivery systems for such drugs are under intensive investigation. Exploiting extracellular vesicles as carriers for biological therapeutics is a promising strategy to overcome these issues and to achieve efficient delivery to the cytosol of target cells. Exosomes are a well studied class of extracellular vesicles known to carry proteins and nucleic acids, making them especially suitable for such strategies. However, the considerable complexity and the related high chance of off-target effects of these carriers are major barriers for translation to the clinic. Given that it is well possible that not all components of exosomes are required for their proper functioning, an alternative strategy would be to mimic these vesicles synthetically. By assembly of liposomes harboring only crucial components of natural exosomes, functional exosome mimetics may be created. The low complexity and use of well characterized components strongly increase the pharmaceutical acceptability of such systems. However, exosomal components that would be required for the assembly of functional exosome mimetics remain to be identified. This review provides insights into the composition and functional properties of exosomes, and focuses on components which could be used to enhance the drug delivery properties of exosome mimetics
The faint stellar halos of massive red galaxies from stacks of more than 42000 SDSS LRG images
We study the properties of massive galaxies at an average redshift of z~0.34
through stacking more than 42000 images of Luminous Red Galaxies from the Sloan
Digital Sky Survey. This is the largest dataset ever used for such an analysis
and it allows us to explore the outskirts of massive red galaxies at
unprecedented physical scales. Our image stacks extend farther than 400 kpc,
where the r-band profile surface brightness reaches 30 mag arcsec-2. This
analysis confirms that the stellar bodies of luminous red galaxies follow a
simple Sersic profile out to 100 kpc. At larger radii the profiles deviate from
the best-fit Sersic models and exhibit extra light in the g, r, i and z-band
stacks. This excess light can probably be attributed to unresolved intragroup
or intracluster light or a change in the light profile itself. We further show
that standard analyses of SDSS-depth images typically miss 20% of the total
stellar light and underestimate the size of LRGs by 10% compared to our best
fit r-band Sersic model of n=5.5 and r_e=13.1 kpc. If the excess light at r>100
kpc is considered to be part of the galaxy, the best fit r-band Sersic
parameters are n=5.8 and r_e=13.6 kpc. In addition we study the radially
dependent stack ellipticity and find an increase with radius from e=0.25 at
r=10 kpc to e=0.3 at r=100 kpc. This provides support that the stellar light
that we trace out to at least 100 kpc is physically associated with the
galaxies themselves and may confirm that the halos of individual LRGs have
higher ellipticities than their central parts. Lastly we show that the
broadband color gradients of the stacked images are flat beyond roughly 40 kpc,
suggesting that the stellar populations do not vary significantly with radius
in the outer parts of massive ellipticals.Comment: Accepted for publication in Ap
Challenges and directions in studying cell-cell communication by extracellular vesicles
Extracellular vesicles (EVs) are increasingly recognized as important mediators of intercellular communication. They have important roles in numerous physiological and pathological processes, and show considerable promise as novel biomarkers of disease, as therapeutic agents and as drug delivery vehicles. Intriguingly, however, understanding of the cellular and molecular mechanisms that govern the many observed functions of EVs remains far from comprehensive, at least partly due to technical challenges in working with these small messengers. Here, we highlight areas of consensus as well as contentious issues in our understanding of the intracellular and intercellular journey of EVs: from biogenesis, release and dynamics in the extracellular space, to interaction with and uptake by recipient cells. We define knowledge gaps, identify key questions and challenges, and make recommendations on how to address these
Disulfide-Based Poly(amido amine)s for siRNA Delivery: Effects of Structure on siRNA Complexation, Cellular Uptake, Gene Silencing and Toxicity
Purpose\ud
\ud
RNA interference (RNAi) is a process by which small interfering RNAs (siRNA) induce sequence-specific gene silencing. Therefore, siRNA is an emerging promise as a novel therapeutic. In order to realize the high expectations for therapeutic applications, efficient delivery systems for siRNA are necessary.\ud
\ud
Methods\ud
\ud
In this study, a new series of biodegradable poly(amido amine)s with disulfide linkages in the backbone was synthesized out of N,Nβ²-cystaminebisacrylamide (CBA), 4-amino-1-butanol (ABOL) and ethylene diamine (EDA). Effects of different percentages of butanolic side chains and protonatable fragments in the main chain on siRNA complexation, cellular uptake, gene silencing and toxicity were investigated.\ud
\ud
Results\ud
\ud
Incorporation of EDA in the polymer resulted in increased siRNA condensation. Efficient siRNA condensation was shown to be necessary for cellular uptake; however, excess of polymer decreased siRNA uptake for polymers with high amounts of EDA. Silencing efficiency did not correlate with uptake, since silencing increased with increasing w/w ratio for all polymers. More than 80% knockdown was found for polyplexes formed with polymers containing 25% or 50% EDA, which was combined with low cytotoxicity.\ud
\ud
Conclusions\ud
\ud
Poly(amido amine)s with minor fractions of protonatable fragments in the main chain are promising carriers for delivery of siRNA\u
Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles
The therapeutic use of RNA interference is limited by the inability of siRNA molecules to reach their site of action, the cytosol of target cells. Lipid nanoparticles, including liposomes, are commonly employed as siRNA carrier systems to overcome this hurdle, although their widespread use remains limited due to a lack of delivery efficiency. More recently, nature's own carriers of RNA, extracellular vesicles (EVs), are increasingly being considered as alternative siRNA delivery vehicles due to their intrinsic properties. However, they are difficult to load with exogenous cargo. Here, EV-liposome hybrid nanoparticles (hybrids) are prepared and evaluated as an alternative delivery system combining properties of both liposomes and EVs. It is shown that hybrids are spherical particles encapsulating siRNA, contain EV-surface makers, and functionally deliver siRNA to different cell types. The functional behavior of hybrids, in terms of cellular uptake, toxicity, and gene-silencing efficacy, is altered as compared to liposomes and varies among recipient cell types. Moreover, hybrids produced with cardiac progenitor cell (CPC) derived-EVs retain functional properties attributed to CPC-EVs such as activation of endothelial signaling and migration. To conclude, hybrids combine benefits of both synthetic and biological drug delivery systems and might serve as future therapeutic carriers of siRNA
Physicochemical and Biological Evaluation of siRNA Polyplexes Based on PEGylated Poly(amido amine)s
PURPOSE: Use of RNA interference as novel therapeutic strategy is hampered by inefficient delivery of its mediator, siRNA, to target cells. Cationic polymers have been thoroughly investigated for this purpose but often display unfavorable characteristics for systemic administration, such as interactions with serum and/or toxicity. METHODS: We report the synthesis of a new PEGylated polymer based on biodegradable poly(amido amine)s with disulfide linkages in the backbone. Various amounts of PEGylated polymers were mixed with their unPEGylated counterparts prior to polyplex formation to alter PEG content in the final complex. RESULTS: PEGylation effectively decreased polyplex surface charge, salt- or serum-induced aggregation and interaction with erythrocytes. Increasing amount of PEG in formulation also reduced its stability against heparin displacement, cellular uptake and subsequent silencing efficiency. Yet, for polyplexes with high PEG content, significant gene silencing efficacy was found, which was combined with almost no toxicity. CONCLUSIONS: PEGylated poly(amido amine)s are promising carriers for systemic siRNA delivery in vivo
- β¦